Monday, September 15, 2025

Triple dose of Novo Nordisk drug delivers 19% weight loss in trials

Danish pharma group seeks to broaden options and stay competitive with Eli Lilly

from News Feed https://ift.tt/FsOw5bo
via IFTTT
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)